Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation by Watts, Gerald F., DSc, MD, PhD, Gidding, Samuel, MD, Wierzbicki, Anthony S., MD, Toth, Peter P., MD, PhD, Alonso, Rodrigo, MD, Brown, W. Virgil, MD, Bruckert, Eric, MD, Defesche, Joep, PhD, Lin, Khoo Kah, MBBS, PhD, Livingston, Michael, Mata, Pedro, MD, Parhofer, Klaus G., MD, PhD, Raal, Frederick J., MD, PhD, Santos, Raul D., MSc, MD, PhD, Sijbrands, Eric J.G., MSc, MD, PhD, Simpson, William G., MD, Sullivan, David R., MBBS, Susekov, Andrey V., MD, PhD, Tomlinson, Brian, MBBS, MD, Wiegman, Albert, MD, PhD, Yamashita, Shizuya, MD, PhD, Kastelein, John J.P., MD, PhD

Get full text

The Efficacy and Safety of Rosuvastatin 5mg in Statin Intolerant Patients: An Observational Study by Wierzbicki, Anthony S., MD, Meek, Claire, MD, Viljoen, Adie, MD, Twomey, Patrick, MD, Crook, Martin, MD, PhD

Get full text

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial by Raal, Frederick J, Prof, Stein, Evan A, Prof, Dufour, Robert, MD, Turner, Traci, MD, Civeira, Fernando, MD, Burgess, Lesley, Prof, Langslet, Gisle, MD, Scott, Russell, Prof, Olsson, Anders G, Prof, Sullivan, David, MD, Hovingh, G Kees, MD, Cariou, Bertrand, MD, Gouni-Berthold, Ioanna, MD, Somaratne, Ransi, MD, Bridges, Ian, MSc, Scott, Rob, MD, Wasserman, Scott M, MD, Gaudet, Daniel, Prof

Get full text

The Effect of a 12-Week Course of Omega-3 Polyunsaturated Fatty Acids on Lipid Parameters in Hypertriglyceridemic Adult HIV-infected Patients Undergoing HAART: A Randomized, Placeb... by Peters, Barry S., MD, Wierzbicki, Anthony S., PhD, Moyle, Graeme, MD, Nair, Devaki, MD, Brockmeyer, Norbert, PhD

Get full text

Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation by Wierzbicki, Anthony S., Lloyd, Matthew D., Schofield, Christopher J., Feher, Michael D., Gibberd, F. Brian

Get full text

Adult Refsum Disease: A Form of Tapetoretinal Dystrophy Accessible to Therapy by Rüether, Klaus, MD, Baldwin, Eleanor, BSc, RD, Casteels, Minne, MD, PhD, Feher, Michael D., MD, FRCP, Horn, Morten, MD, Kuranoff, Susan, MA, Leroy, Bart P., MD, PhD, Wanders, Ronald J., PhD, Wierzbicki, Anthony S., DM, Dphil, FRCPath

Get full text

The chemical biology of branched-chain lipid metabolism by Mukherji, Mridul, Schofield, Christopher J., Wierzbicki, Anthony S., Jansen, Gerbert A., Wanders, Ronald J.A., Lloyd, Matthew D.

Get full text

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease by MUKHERJI, Mridul, CHIEN, Winnie, KERSHAW, Nadia J, CLIFTON, Lan J, SCHOFIELD, Christopher J, WIERZBICKI, Anthony S, LLOYD, Matthew D

Get full text

Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease by Wierzbicki, Anthony S., Mayne, Phillip D., Lloyd, Matthew D., Burston, David, Mei, Guam, Sidey, Margaret C., Feher, Michael D., Gibberd, F. Brian

Get full text

‘Chemical co-substrate rescue’ of phytanoyl-CoA 2-hydroxylase mutants causing Refsum’s Disease by Mukherji, Mridul, Kershaw, Nadia J., MacKinnon, Colin H., Clifton, Ian J., Schofield, Christopher J., Lloyd, Matthew D., Wierzbicki, Anthony S.

Get full text

Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-Coenzyme A by Kershaw, Nadia J, Mukherji, Mridul, MacKinnon, Colin H, Claridge, Timothy D.W, Odell, Barbara, Wierzbicki, Anthony S, Lloyd, Matthew D, Schofield, Christopher J

Get full text